Abstract
This book wants to analyse the intersection between drugs and gender. On the one hand, drugs can be gendered and tailored to focus on either men or women. On the other hand, they articulate gendered subjectivities for us, so they can engender us. This work has taken its theoretical perspective from feminist techno-science studies. From a posthuman approach, analysis extends to nonhumans as active agents. A feminist critique is included with the concern for masculinities, non-binary sex/gender understandings and the intersection with race, class, sexuality and global inequalities.
 The book has used a wide fieldwork, as drug pharmaceutical advertisements, medical guidelines and the experience of some of the people directly affected by the side effects of some of tools for health. It is a relevant contribution for it is an approach to gender construction from nonhumans, which highlight the subjective processes in science. It throws some light on the construction of bodies and subjects in relation to pharmaceuticals, and the multiplicity of such material-discursive entanglement from a critical perspective of the biomedical power.
Highlights
The work is theoretically premised in feminist technoscience studies with an interest in materialdiscursive bodies (Haraway, 1997; Barad, 2007) and how pharmaceuticals produce bodies and gender (Petryna et al, 2006)
It takes the example of alpha-blockers used to treat lower urinary tract secondary symptoms of benign prostate hyperplasia (LUTS/benign prostatic hyperplasia (BPH)) to develop an analysis based on Karen Barad’s (2007) concepts of actant and intra-action
The Lisa Lindén studies Gardasil the vaccine advertisements produced by pharmaceutical company Sanofi Pasteur in Sweden against cancer caused by human papillomavirus (HPV) aimed at young girls
Summary
The work is theoretically premised in feminist technoscience studies with an interest in materialdiscursive bodies (Haraway, 1997; Barad, 2007) and how pharmaceuticals produce bodies and gender (Petryna et al, 2006). Part I analyses pharmaceuticals in different life phases and adjacent health concerns, such as Alzheimer’s disease, prostate treatments or trans-childhood. We show that in Alzheimer’s research are fly models tested upon, research produces sex differences.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
